One 9p penny stock I’m loading up on in 2024

This penny stock has fallen more than 50% over the past two years despite encouraging progress being made at the portfolio level.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Light bulb with growing tree.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve been adding to my holding in Agronomics (LSE: ANIC) all year long. And I intend to keep buying this penny stock throughout 2024.

However, I plan to invest opportunistically, picking up shares when there’s selling pressure. Fortunately, this shouldn’t be a problem as this market cap minnow does tend to yo-yo quite a bit.

Here’s why I’m bullish heading into the New Year.

Buffeted by interest rate speculation

There’s been a lot of share price volatility recently, even by Agronomics’ standards.

The stock surged 20% to 11p in November when it looked like interest rates might start coming down next year. Then it fell back down to 9p when that suddenly looked less likely.

Of course, this makes sense. Agronomics is a venture capital firm and start-ups need capital to get off the ground. Yet we’re no longer in the era of near-zero interest rates when cheap capital was abundant.

Therefore, the risk of companies in general going under is higher, which explains why shares of Agronomics have lost half their value since late 2021.

What is cellular agriculture?

Today, the firm has over 20 early-stage companies in its portfolio. The aim is to nurture a couple of big winners in the emerging industry of cellular agriculture, with the hope that these will more than offset the inevitable failures.

For those unfamiliar, cellular agriculture is the production of animal-based products (meat, milk, eggs and more) from stem cell cultures rather than directly from animals.

Importantly, this meat is real and not plant-based.

Beyond improved animal welfare, there are many benefits to this method of food production. These include:

  • Land Use: Significantly less land and water needed compared to traditional farming
  • Emissions: Lower greenhouse gas emissions compared to livestock farming
  • Health: Lab-grown meat is unlikely to require many antibiotics, reducing the risk of antibiotic resistance in both animals and humans
  • Food Security: No reliance on weather conditions or seasons, leaving nations less vulnerable to food supply chain shocks (conflict in grain-producing Ukraine, for example)

Cellular agriculture lies at the intersection of some of the biggest trends of this century.

Promising portfolio progress

Despite the challenging macro backdrop, many of the firm’s top holdings have had no problem raising capital recently. Indeed, money continues to pour into the space.

Source: GlobalData

BlueNalu, for example, raised $33.5m in funding in October. This firm is a global leader in cell-cultured seafood (fish that hasn’t been fished, basically).

Its first product is a lab-grown portion of bluefin tuna, which it plans to commercialise in several Asia Pacific nations.

Agronomics now holds a 5.12% stake in BlueNalu. If this start-up goes public or is acquired, I’d expect some tasty gains for Agronomics shareholders.

The future

Now, there’s no certainty when — or even if — these cell-based products will go mainstream. After all, we live in the internet age when even the science behind vaccines regularly gets questioned. So I’d expect some scepticism about meat grown entirely outside of an animal’s body.

Yet some of these products have already been approved by regulators. And analysts at Barclays see the alternative meat market growing tenfold between 2021 and 2031.

This penny stock offers everyday investors like myself a way to get in very early on this emerging mega-trend.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in Agronomics. The Motley Fool UK has recommended Barclays Plc and GlobalData Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Should I sell my FTSE All-Share index fund and buy a S&P 500 tracker instead?

Harvey Jones is wondering whether now is a good time to invest more money in the S&P 500, after a…

Read more »

Investing Articles

Should I buy dirt-cheap BT shares after the recent pullback?

BT shares were on the up but now they're sliding again after the board trimmed full-year guidance. Now Harvey Jones…

Read more »

Investing Articles

Up 28%, can the easyJet share price keep rising?

The easyJet share price has gained altitude over one year but plunged over five. Is now an attractive time for…

Read more »

British Isles on nautical map
Investing Articles

Should I buy more BAE Systems shares at 1,350p?

BAE Systems shares have had a fantastic run since early 2022, yet still don't appear overvalued. Is it now time…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

7% yield and a cheap valuation! Is this one of the best shares to buy this month?

Christopher Ruane has been looking for cheap shares to buy. This one has a 7% dividend yield, so is it…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Should I buy National Grid shares for the big dividend before it’s too late?

This year's price weakness has left National Grid shares on what looks like a tempting valuation. I hope it doesn't…

Read more »

Investing Articles

There are now 5,000 ISA millionaires! See the surprising UK dividend shares they’re buying

The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

Down 38% in weeks! Time to snap up NIO stock?

NIO stock's more than doubled in value over the past five years but has been on a wild ride lately.…

Read more »